Thermoplastic compounder Foster Corp. has unveiled a clean room at its Putnam, Conn., site to meet demand brought on by the convergence of medical-device and pharmaceutical technologies.
The 900-square-foot, Class 100,000 clean room opened in June. The company had moved into the 45,000-square-foot compounding facility earlier this year, more than doubling the space from its previous 20,000-square-foot site in nearby Dayville, Conn.
Foster added a Leistritz ZSE 27-millimeter, twin-screw extruder for the clean room, which also has quartz/epoxy seamless floors, a fume and dust collection system, interlock ``pass-through'' for materials and a gowning room.
``We believe drug-coated stents and transdermal wound care represent only the beginning of a convergence between device and drug applications, which will require more precise and cleaner material manufacturing,'' said Ken Pickering, vice president and chief operating officer.
The Putnam-based firm has invested $4.5 million at the facility, which employs about 40. The firm also runs a 13,000-square-foot, 15-employee plant in Las Vegas that provides some special-needs compounding and other services, the spokesman said.
Foster manufactures a variety of materials, including thermoplastics, TP elastomers, polyurethanes and fluoropolymers. The Putnam facility also was built to produce nanocomposites, water-soluble polymers and other specialty formulations.
The firm is projecting year-over-year sales growth of about 10-20 percent.